IGF1R and preeclampsia: Much less widely accepted, however, is that preeclampsia may protect against later life maternal breast cancer development, as the evidence is mixed depending on specific cohort characteristics and whether or not a woman’s inherited genotype for the common insulin-like growth factor receptor-1 (IGF1R) gene variant rs2016347 is also considered [2–4].